An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM). For cervical cancer, 94% of deaths occur in low- and middle-income countries (350,000 women died in 2022). Ra ...

The ARCHERY team are pleased to confirm the study has surpassed it's recruitment target of 990 participants (330 per tumour type)! Since recruiting the first participant in December 2023, our sites in India, Jordan, Malaysia and South Africa have worked hard to meet these targets and you can read more about the teams involved on our centres pages here.  You can see the progres ...

Today, on World Radiotherapy Awareness Day, we recognise the life-saving role of radiotherapy in cancer care and showcase ARCHERY, a study aiming to improve the radiotherapy planning pathway in low and middle-income countries (LMICs). Radiotherapy plays a crucial role in cancer treatment. It helps cure of about 40% of cancers and is a necessary part of treatment for approximat ...

The ARCHERY team are pleased to confirm the study has reached it's recruitment target of 330 for the prostate cancer patient group! Since recruiting the first participant in December 2023, our sites in India, Jordan, Malaysia and South Africa have worked hard to meet these targets and you can read more about the teams involved on our centres pages here. The study plans to recru ...

We are delighted to confirm that ARCHERY has now surpassed 75% of its recruitment goal! We have consented 900 participants with 67 withdrawals, reaching a total of 833 currently enrolled participants. This means we have reached just over 84% of our goal of 990.  See below for a breakdown of our progress so far by site. For more regular updates on recruitment figures see our C ...